The effect of Methylphenidate on sleep and circadian rhythm in adult ADHD measured with actigraphy and the dim light melatonin onset (DLMO)
Completed
- Conditions
- 10012562Attention deficit/hyperactivity
- Registration Number
- NL-OMON35707
- Lead Sponsor
- Pro Persona Veluwe Vallei (Ede)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
Adult ADHD patients between 21-60 years old
Exclusion Criteria
Use of medication which influences sleep and/or the endogenous melatonin production
recent traveling within more than one time zone or participation in shift work
Substance abuse
Contraindications for the use of methylphenidate
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>DLMO (Dim light melatonin onset)<br /><br>Circadian actografic parameters<br /><br>PAD (phase angle difference)</p><br>
- Secondary Outcome Measures
Name Time Method <p>subjective sleepparameters measured with self reporting lists</p><br>